What do all those radiation treatment modality codes mean?

The regional treatment modality fields for radiation therapy can be tricky when deciding on the appropriate code to assign. The regional treatment modality field is used to record the dominant modality of radiation therapy used to deliver the most clinically significant regional dose to the primary volume of interest during the first course of treatment. […]

Bringing Awareness to Kidney Cancer

March is kidney cancer awareness month. So what is the role of our kidneys? The kidneys are bean shaped organs located on each side of the mid back. The kidneys are retroperitoneal organs that lie behind the peritoneum that lines the abdominal cavity. The main function of the kidneys are to filter the blood and […]

Best Practices to Meet Cancer Registry Reporting Deadline

Cancer registries are legislatively mandated to collect confidential data on tumor characteristics, monitor cancer trends, aid in epidemiologic research, and collect quality cancer data elements. Abstracting Timeliness and what this means to you: Abstracting timeliness entails the completion of all analytic cases within six months from the date of initial diagnosis must be reported to […]

Cancer Registrars: When to Report Class of Case 00 vs. 10

As a cancer registrar, ask yourself this question: Have you ever been involved in a lengthy discussion about the use of Class of Case 00 vs. 10? Is it frequently difficult to determine which Class of Case is more appropriate?  If you answered “yes” to either or both of these questions, you are not alone. […]

Text Fields And The Cancer Registrar: Telling The Complete Story

  Cancer Registry Data A cancer registry abstract provides a quick glimpse into each patient’s unique story. As part of this abstract, coded data provides specific details about the cancer, such as the disease process or specific treatment that patients undergo in each facility. However, to paint a complete picture, coded data must be supplemented […]

New study suggests registry gaps in follow-up information for certain cancers

Standards 5.3 and 5.4 of the American College of Surgeons’ (ACoS) Cancer Program Standards 2012, Version 1.2.1: Ensuring Patient-Centered Care require cancer registries to perform follow-up for 80%–90% of analytic cases. This includes recording vital status, cancer status, and date of last contact. Although cancer registry follow-up guidelines exist, these guidelines are not tailored to […]

Colorectal Cancer Awareness

  More than 140,000 people are diagnosed with colorectal cancer every year, according to the Center for Disease Control and Prevention (CDC). More than 50,000 die from the disease annually. What’s worse is that colorectal cancer is the second leading cause of cancer deaths in the United States. More than 90% of colorectal cancers occur […]

Understanding the Functions of Different Chemotherapy Agents

Chemotherapy is one of many treatment options for patients with cancer. This form of therapy uses chemical agents (i.e., anti-cancer or cytotoxic drugs) that interact with cancer cells to eradicate or control the growth of cancer. Common alternative forms of treatment include surgery to remove all or a portion of a tumor as well as […]

Quality Improvement Meets Oncology

Why QOPI Programs Matter Quality Oncology Practice Initiative programs are designed for hematology-oncology physician-based practices. Strictly voluntary, QOPI programs provide a valuable tool to assess current practice standards. QOPI Methods and Measurement Chart abstraction is performed twice a year, spring and fall, and covers a five week period. During this collection process, practices participate in […]

Mycosis Fungoides: CS-Ext and CS-SSF1

Mycosis fungoides (9700/3), also known as Alibert-Bazin syndrome, is the most common type of primary cutaneous T-cell lymphoma.  The name Mycosis fungoides loosely means “mushroom-like fungal disease.” It is so named because the skin tumors, particularly of severe cases, have mushroom-like appearance.   However, it is not a fungal infection but rather a type of non-Hodgkins […]